Critical Care & Emergencies (all articles)
Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review
23 Mar, 2021 | 02:31h | UTC
Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study
23 Mar, 2021 | 02:20h | UTC
Commentary on Twitter
Lung #ultrasound based approach for early diagnosis of #COVID19 pneumonia:
➡️20 US/European hospitals
➡️1462 pts
Combining #LUS patterns of probability + clinical characteristics allow to rapidly rule in/out #SARSCoV2 pneumonia at bedside w high accuracy!https://t.co/GqsOZoIdgc pic.twitter.com/eENciXi9Cf— Intens Care Med (@yourICM) March 20, 2021
Expert consensus statements for the management of COVID-19-related acute respiratory failure
21 Mar, 2021 | 22:05h | UTC
Commentary on Twitter
?Expert consensus statements for the management of ?? COVID-19-related acute respiratory failure using a Delphi method.
?????https://t.co/ujt8669VAb pic.twitter.com/AlT0ZkdKSc— RECAT??⚕️???⚕️ (@LeslieMegom) March 17, 2021
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
21 Mar, 2021 | 21:49h | UTC
Commentary on Twitter
@JACCJournals: We share a systematic summary of #anticcogulation,#antiplatelet, and #fibrinolysis #RCTs in #COVID19. Amazing work by @AzitaTalasaz and a stellar multidisciplinary team! Figs illustrate areas where we’ll have evidence, & the gaps. Link: https://t.co/t4ksxwjAze pic.twitter.com/0Th3OZBXOY
— Behnood Bikdeli (@bbikdeli) March 16, 2021
RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit
19 Mar, 2021 | 08:42h | UTCEditorial: Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19 – JAMA
Commentary on Twitter
Intermediate-dose prophylactic enoxaparin (1 mg/kg/d) had no effect on a primary composite outcome of adjudicated venous or arterial thrombosis, ECMO, or 30-d mortality vs standard dose enoxaparin among ICU patients w #COVID19 https://t.co/L6UdB31J7V
— JAMA (@JAMA_current) March 18, 2021
Current evidence for COVID-19 therapies: a systematic literature review
19 Mar, 2021 | 08:36h | UTC
How do you treat coronavirus? Here are physicians’ best strategies
19 Mar, 2021 | 08:33h | UTCHow do you treat coronavirus? Here are physicians’ best strategies – Science (a few articles per month are free)
Video: Coronavirus Update with Carlos del Rio and Preeti Malani
19 Mar, 2021 | 08:24h | UTCCoronavirus Update With Carlos del Rio and Preeti Malani – JAMA
Review: Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke
18 Mar, 2021 | 08:54h | UTCDiagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review – JAMA
The use of extracorporeal CO2 removal in acute respiratory failure
18 Mar, 2021 | 08:47h | UTCThe use of extracorporeal CO2 removal in acute respiratory failure – Annals of Intensive Care
Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19
18 Mar, 2021 | 09:05h | UTCThoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library
Consensus Document: Management of acute myocarditis and chronic inflammatory cardiomyopathy
17 Mar, 2021 | 02:28h | UTC
A randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department
17 Mar, 2021 | 02:13h | UTCA randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department – Academic Emergency Medicine (link to abstract – $ for full-text)
Commentaries: Lower dose of ketamine is as effective as the standard dose to treat pain in adults – Loyola University Health System AND Lower doses of ketamine shown to be non-inferior for acute pain control in the emergency setting – 2 Minute Medicine
FDA: Why you should not use Ivermectin to treat or prevent COVID-19
17 Mar, 2021 | 02:51h | UTCWhy You Should Not Use Ivermectin to Treat or Prevent COVID-19 – U.S. Food & Drug Administration
Commentary: FDA Rejects Ivermectin, Despite Growing Interest In Some Corners Of The Internet – Brief19
Related: RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19
COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies
17 Mar, 2021 | 02:52h | UTC
Commentary on Twitter
How common are pre‐existing heart & blood vessel problems in #COVID19? What are most common complications affecting heart & blood vessels in #COVID19? @CochraneHeart review of prevalence studies: https://t.co/rDqz2GyrpH
— The Cochrane Library (@CochraneLibrary) March 12, 2021
COVID antibody treatments show promise for preventing severe disease
17 Mar, 2021 | 02:46h | UTCCOVID antibody treatments show promise for preventing severe disease – Nature
Consensus Statement on Analgo-sedation in Neurocritical Care and Review of Literature
17 Mar, 2021 | 02:09h | UTC
RCT: No benefit from probiotic therapy in critical illness
16 Mar, 2021 | 01:30h | UTC
Commentary on Twitter
Early & sustained untargeted administration of probiotics to adults admitted to #ICU safe, but not associated with improved outcomes. ROCIT, restoration of gut microflora in critical illness, trial visual abstract full text open access #FOAMcc on @yourICM https://t.co/mP4bkHpqSs pic.twitter.com/bu3EGUyDCm
— Intens Care Med (@yourICM) March 15, 2021
Platelet tests pre-CABG may safely shorten washout waits, cut costs
16 Mar, 2021 | 01:44h | UTCPlatelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs – TCTMD
B.1.1.7 variant linked to 55% higher mortality compared to other strains of SARS-CoV-2
16 Mar, 2021 | 02:32h | UTCOriginal study: Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 – Nature
Related: Death rate 64% higher with B117 COVID variant, study finds (study and commentary)
Commentary on Twitter (thread – Click for more)
https://mobile.twitter.com/_nickdavies/status/1371441682089132032
Editorial: How I prescribe continuous renal replacement therapy
16 Mar, 2021 | 01:27h | UTCHow I prescribe continuous renal replacement therapy – Critical Care
The oxygen cascade during exercise in health and disease
16 Mar, 2021 | 01:28h | UTCThe Oxygen Cascade During Exercise in Health and Disease – Mayo Clinic Proceedings
Revisiting the Ten Commandments of Emergency Medicine: A Resident’s Perspective
14 Mar, 2021 | 20:26h | UTCRevisiting the Ten Commandments of Emergency Medicine: A Resident’s Perspective – Annals of Emergency Medicine (free for a limited period)
Commentary: Ten Commandments of Emergency Medicine Revisited – Journal Feed
New COVID-19 risk calculator can predict severe disease or death among hospitalized patients with COVID-19
14 Mar, 2021 | 20:54h | UTCSee calculator: Severe COVID-19 Adaptive Risk Predictor (SCARP)
[Preprint] RCT: Full-dose/therapeutic anticoagulation provides no benefit in critically ill patients with Covid-19
14 Mar, 2021 | 20:59h | UTCTherapeutic Anticoagulation in Critically Ill Patients with Covid-19-Preliminary Report – medRxiv
Related (results on moderately ill patients): [Not published yet] Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials